CIK 0001723128 · Large accelerated filer
Amneal Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- Phone
- (908) 947-3120
- Former names
- Atlas Holdings, Inc.
- 4 Option exercise Executive Vice President & CFO acquired 45,289 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Executive Vice President gave up 19,685 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Legal Officer gave up 8,164 shares (to pay taxes)
- POS AM Other Post-effective Amendment for Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- 10-K Report Annual Report
- 4 Shares withheld for taxes Executive Vice President gave up 22,967 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Vice President gave up 22,059 shares (to pay taxes)
- 4 Option exercise Executive Vice President & CFO acquired 36,197 shares (option exercise)
- POSASR Other POSASR
- POSASR Other POSASR
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Shares withheld for taxes Executive Vice President gave up 17,557 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Vice President gave up 19,752 shares (to pay taxes)
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Results of operations · Regulation FD disclosure
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale Former 10% Owner sold 3,884,600 shares at $2.34 ($9,095,402)
Page 16 of 35 · 695 filings